Iranian Society of Gynecology Oncology


1 Department of Obstetrics and Gynecology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, IR Iran

2 Department of Hematology and Oncology, Ayatollah Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran

3 Department of Obstetrics and Gynecology, Iran University of Medical Sciences, Tehran, IR Iran


Introduction: Sarcoma of the cervix is uncommon and its prevalence is about 1% of malignancies of the cervix. One type of sarcoma is leiomyosarcoma and the location of this tumor in cervix is very rare. Although uterine sarcoma can involve the cervix and lead to misdiagnosis of cervical leiomyosarcoma, the location of the bulk of the tumor in uterine cervix (not isthmus) for diagnosis of cervical leiomyosarcoma is mandatory. The origin of sarcoma is from mesodermal tissue. Due to the rarity of cervical leiomyosarcoma and response to debulking surgery after recurrence, report of this case is interesting.
Case Presentation: We hereby report on a 34-year-old unmarried patient, who was a known case of leiomyosarcoma of uterine cervix that was referred with recurrence of tumor in parietal peritoneum, retropobic retzius space and around the bladder and ureter and sigmoid colon. The patient was treated with debulking surgery of the tumor and chemotherapy.
Conclusions: Sarcoma as a genital tract malignancy is very rare and the location of sarcoma at pediatric age is in the vagina and at middle age is in the cervix and at postmenopausal women in the uterine corpus. Cervical sarcoma as a rare tumor of the cervix arises from stromal tissue. Due to hematogenous spread of sarcoma, metastasis in lungs is seen and recurrence of this tumor is not uncommon. In this article, recurrence of a known case with leiomyosarcoma of uterine cervix in previous hysterectomy that responded to debulking surgery with removal of metastatic lesions in peritoneal and retroperitoneal spaces and adjuvant therapy with standard chemotherapy drugs and monoclonal antibody therapy is reported. Due to non-hormonal dependence of sarcoma to hormonal secretion from the ovaries and benefit of the ovaries in young women for protection of bone health and cardiovascular system, oophorectomy is a challenging idea and an issue of debate, thus primary surgery, in this case oophorectomy, was not done.


  1. Fadare O. Uncommon sarcomas of the uterine cervix: a review of selected entities. Diagn Pathol. 2006;1:30. [DOI:10.1186/1746-1596-1-15]
  2. Rotmensch J, Rosenshein NB, Woodruff JD. Cervical sarcoma: a review. Obstet Gynecol Surv. 1983;38(8):456-60. [DOI:10.1097/00006254-198308000-00002]
  3. Sahu L, Bupathy A, Badhe BA. Leiomyosarcoma of the uterine cervix in a young woman. J Obstet Gynaecol Res. 2008;34(4 Pt 2):717-20. [DOI:10.1111/j.1447-0756.2008.00914.x]
  4. Wright JD, Rosenblum K, Huettner PC, Mutch DG, Rader JS, Powell MA, et al. Cervical sarcomas: an analysis of incidence and outcome. Gynecol Oncol. 2005;99(2):348-51. [DOI:10.1016/j.ygyno.2005.06.021]
  5. Doshi B, Shetty S, Safaya A. Leiomyosarcoma of cervix. J Obstet Gynaecol India. 2013;63(3):211-2. [DOI:10.1007/s13224-012-0191-3]
  6. Mehra R, Sidhu S, Pandey A, Garg S. A rare case of leiomyosarcoma of cervix and challenges in its management. Int J Res Med Sci. 2015;3(1):320-24. [DOI:10.5455/2320-6012.ijrms20150161]
  7. Lack EE. Leiomyosarcomas in childhood: a clinical and pathologic study of 10 cases. Pediatr Pathol. 1986;6(2-3):181-97. [DOI:10.3109/15513818609037711]
  8. Gotoh T, Kikuchi Y, Takano M, Kita T, Ogata S, Aida S. Epithelioid leiomyosarcoma of the uterine cervix. Gynecol Oncol. 2001;82(2):400-5. [DOI:10.1006/gyno.2001.6288]
  9. Irvin W, Presley A, Andersen W, Taylor P, Rice L. Leiomyosarcoma of the cervix. Gynecol Oncol. 2003;91(3):636-42. [DOI:10.1016/j.ygyno.2003.08.037]
  10. Dhull AK, Kaushal V, Marwah N. The uncovered story of leiomyosarcoma of the cervix: a rare case report and review of literature. BMJ Case Rep. 2013;2013. [DOI:10.1136/bcr-2013-008616]